AEVEX Corp.

Date of prospectus: April 9, 2026

AEVEX Corp. IPO: Deep Dive Analysis of a High-Growth Aerospace Entrant Targeting NYSE Debut (Symbol: AVEX)

AEVEX Corp. is launching its initial public offering (IPO) at a pivotal moment for the aerospace and defense sector. With a robust funded backlog, impressive revenue growth, and a focus on government contracts, AEVEX is set to list on the NYSE under the ticker AVEX. This analysis dissects the offer structure, financials, risks, growth strategy, and market outlook, providing investors with the key data and insights needed to assess the IPO’s potential.

IPO Snapshot

Key facts and offer structure for AEVEX Corp.’s initial public offering:

• IPO Symbol: AVEX
• Exchange: New York Stock Exchange (NYSE) – listing application submitted
• Offer Price Range: \$18.00 – \$21.00 per share
• Assumed Offer Price (Midpoint): \$19.50 per share
• Shares Offered: 16,000,000 Class A common stock
• Over-allotment Option (Greenshoe): 1,717,847 shares from AEVEX Corp. and 682,153 shares from the selling stockholder
• Post-IPO Outstanding Shares: 48,529,019 Class A common stock (or 50,246,866 if greenshoe exercised in full); 63,297,524 Class B shares
• Offer Size (Estimated): ~\$278.3 million net proceeds (excluding greenshoe; at \$19.50/share)

Use of Proceeds: Deleveraging and Growth Platform

The primary use of IPO proceeds is debt repayment. AEVEX intends to invest approximately \$278.3 million to acquire 16,000,000 newly-issued Series A Units in Holdings LLC. Holdings LLC will apply the net proceeds as follows:

• Repay \$257.8 million in outstanding borrowings under the company’s Credit Agreement (Term Loan interest: 9.92%)
• Cover offering and organizational transaction expenses
• General corporate purposes

Any proceeds from the greenshoe (over-allotment) exercised by underwriters will be used similarly or paid to the selling stockholder (\$12.5 million if fully exercised).

This signals a deleveraging story, reducing leverage and interest expenses to strengthen the balance sheet and position the company for growth and flexibility [[41]], [[101]], [[168]].

Dividend Policy

AEVEX does not plan to pay dividends in the foreseeable future. All earnings are expected to be retained for business investment. Future dividends, if any, will be at the Board’s discretion and contingent on financial results, cash needs, and other factors [[42]].

Placement and Issuance Breakdown

Shares are offered via a traditional public offering with a reserved share program allocating up to 5% of the offer to directors, officers, employees, distributors, dealers, business associates, and related persons through BofA Securities. Any reserved shares not purchased will be offered to the general public on the same terms. There is also a selling stockholder component for oversubscription [[3]], [[43]], [[219]].

Investor Participation & Book Quality

Anchor or cornerstone investors are not named, and specific oversubscription metrics or tranche allocations are not disclosed. Book quality for the offering is therefore not directly assessable from provided information. However, the inclusion of a Reserved Share Program and the broad underwriting syndicate suggest the company expects strong, diversified demand [[3]], [[43]], [[219]].

Deal Parties & Underwriting Structure

Lead Underwriters and Bookrunners:

• Goldman Sachs & Co. LLC (Lead Left)
• BofA Securities, Inc.
• Jefferies LLC
• J.P. Morgan Securities LLC
• RBC Capital Markets, LLC
• Robert W. Baird & Co. Incorporated
• William Blair & Company, L.L.C.
• Raymond James & Associates, Inc.
• Needham & Company, LLC
• Academy Securities, Inc.
• Capital One Securities, Inc.
• PNC Capital Markets LLC

Solebury Capital LLC acts as financial adviser. The underwriters have an option for overallotment. Stabilization activities and standard lock-ups are in place (180 days) [[3]], [[217]], [[219]], [[270]].

The breadth and prominence of the syndicate indicate substantial support for the listing. The Reserved Share Program and participation of leading Wall Street banks suggest strong placement confidence on listing day.

Company Overview: Business Model and Market Position

AEVEX Corp. provides advanced aerospace solutions, primarily to U.S. government agencies and the Department of Defense (DoW). The business model is built on:

• Products: Advanced tactical systems and platforms
• Services: Integrated solutions, including mission operations, intelligence, and support
• Customer Segments: U.S. government (primary), select foreign governments, and commercial partners

Revenue is derived from both long-term and short-cycle contracts, with a high concentration in government defense spending [[32]], [[132]], [[201]].

Industry/sector: Aerospace and defense, with a focus on tactical systems and global solutions. Sector size is not quantified, but AEVEX describes a pipeline of identified growth opportunities at \$8.1 billion as of December 2025 (up 98% YoY) [[17]].

Geography: Primarily United States, with select international exposure.

Financial Health: Revenue, Profitability, Cash Flow, Debt

AEVEX has demonstrated rapid revenue growth but experienced margin compression and a net loss in the most recent year. Key financials are summarized below.

Funded backlog soared 181% YoY to \$503.1 million as of December 31, 2025, illustrating strong forward visibility [[17]].

Market Position, Competitive Advantages, and Management

AEVEX boasts a robust funded backlog, a 28.4% win rate on new “full and open” bids, and a 99%+ win rate on options and recompetes. The company is well positioned in the U.S. government aerospace segment, with significant follow-on and sole-source business [[17]].

Equity sponsor: Madison Dearborn Partners, LLC (MDP) remains the controlling shareholder post-IPO (79.1% voting power).

Management Team and Board: Named directors include Bradley Feldmann, Matthew Klein, Brandon Levitan, and Matthew Norton. The prospectus notes five independent directors at IPO close, with audit and compensation/nominating committees established [[34]], [[181]].

Industry Trends and IPO Timing

Sector demand is driven by U.S. and allied defense budgets, evolving security requirements, and increased demand for tactical intelligence and mission solutions. The company’s pipeline nearly doubled year-on-year, reflecting favorable industry momentum [[17]].

Timing: Shares are expected to deliver in New York, NY, on or about the listing date (2026, exact date TBD). The offer period and allotment window are not specified [[3]].

Market environment: AEVEX’s prospectus cites robust growth in pipeline and funded backlog, suggesting strong sectoral and company-specific momentum at the time of listing [[17]].

Recent Developments

• Backlog growth: 181% increase YoY to \$503.1 million (Dec 2025)
• Pipeline growth: 98% increase YoY to \$8.1 billion (Dec 2025)
• Net income swing: From \$78.6 million profit (2024) to \$(16.8) million loss (2025), due to higher SG&A, R&D, and other one-off expenses

Risk Factors

Key risks disclosed:

• Customer concentration: Heavy reliance on U.S. government/DoW contracts
• Budget and procurement risk: Exposure to U.S. and foreign government spending priorities, delays, or changes
• Contract risk: Subject to competitive bidding, audits, potential for modification or termination
• Market competition: Highly competitive landscape with larger, better-resourced peers
• Internal controls: Material weaknesses identified in financial reporting
• Leverage: High pre-IPO debt load, addressed via IPO proceeds
• Corporate governance: Controlled company status, board structure exemptions, and provisions limiting shareholder action
• Tax Receivable Agreement: Potentially substantial post-IPO payments required to pre-IPO owners
• Other risks: Supply chain, IP protection, inventory management, and public company reporting requirements [[32]], [[33]], [[92]]

Growth Strategy

AEVEX’s growth strategy centers on:

• Leveraging its track record and existing government relationships to win new work
• Expanding into adjacent defense and intelligence markets
• Increasing R&D investment (R&D spend doubled YoY to \$25.4 million in 2025)
• Pursuing select M&A and strategic partnerships
• Continued innovation in tactical systems and mission solutions

Backlog and pipeline growth suggest momentum, and deleveraging post-IPO enhances flexibility for organic and inorganic expansion [[17]], [[34]].

Ownership & Lock-ups

Pre- and post-IPO structure:

• MDP (Madison Dearborn Partners) will control 79.1% of voting power post-IPO (76.7% if greenshoe fully exercised)
• Public float (Class A): 16,000,000 shares (or 17,717,847 if greenshoe exercised)
• Lock-up: 180 days for company, directors, officers, and key stockholders
• 11,182,654 Class A shares reserved for the 2026 Omnibus Incentive Plan (ESOPs/management options)

Valuation and Peer Comparison

Valuation multiples and peer comparisons are not disclosed in the prospectus. No peer company ticker symbols or sector performance tables are provided. Therefore, no direct comparison can be drawn.

Research & Opinions

No analyst coverage, price targets, or third-party opinions are published in the prospectus.

Listing Outlook

Based on the disclosed facts, AEVEX’s IPO is anchored by strong sector momentum, a blue-chip underwriter syndicate, and rapid backlog and pipeline growth. However, investors should note recent net losses, free cash outflows, customer concentration, and the company’s reliance on cyclical government budgets.

Market debut is likely to be supported by the underwriter syndicate and the reserved share program may provide initial price stability. With the offer price at \$19.50/share (midpoint), and given the post-IPO book value per share of \$1.07, investors face significant initial dilution (\$18.43/share). The substantial reduction in leverage and increased liquidity position the company for flexibility, but profitability and operating margin expansion will be critical for sustained equity performance.

Inferred first-day trading range: The IPO may price near the middle of the range and open with moderate support, but valuation sensitivity and government contract exposure could moderate large day-one gains.

Prospectus Access

The IPO prospectus, company reports, and further information are available at: www.sec.gov and www.aevex.com